Thursday, August 28, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Wall Street Analysts Boost Price Targets for Xometry Following Strong Quarterly Results

Felix Baarz by Felix Baarz
August 28, 2025
in Stocks
0
Xometry Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The digital manufacturing marketplace Xometry continues to garner a “Moderate Buy” consensus rating from Wall Street analysts. This assessment is supported by nine research firms, with six recommending a ‘Buy’ and three maintaining a ‘Neutral’ stance. The collective average price target for the stock stands at $40.44.

Impressive Q2 2025 Performance Drives Optimism

The recent wave of analyst upgrades is firmly rooted in the company’s exceptional second-quarter financial performance, which handily surpassed market expectations. Xometry reported a significant year-over-year revenue increase of 22.6%, achieving a total of $162.55 million against an anticipated $156.53 million. Earnings per share also outperformed, coming in at $0.09 compared to the $0.05 forecast. A key profitability metric, Adjusted EBITDA, showed a substantial improvement of $6.6 million year-over-year to reach a positive $3.9 million. Reflecting this strong momentum, the stock hit a 52-week high of $48.64 on August 22, representing a remarkable 143.44% gain over the past twelve months.

A Series of Upward Revisions

This robust operational performance has triggered a succession of positive adjustments from financial institutions, indicating a widespread reassessment of Xometry’s growth potential. The flurry of activity began in early August:

Should investors sell immediately? Or is it worth buying Xometry?

  • Cantor Fitzgerald upgraded its rating from “Underweight” to “Neutral” on August 5, simultaneously establishing a $41 price target.
  • On August 6, UBS raised its target from $35 to $40, though it maintained a “Neutral” recommendation.
  • Also on August 6, JMP Securities issued a more bullish revision, increasing its price objective from $45 to $50 and reaffirming its “Market Outperform” rating.
  • Earlier, on June 3, JPMorgan had increased its target from $36 to $38, maintaining an “Overweight” position on the stock.

Record Quarterly Revenue Fuels Growth

The core driver behind this analyst enthusiasm is the platform’s exceptional operational performance. Xometry’s marketplace segment was the primary growth engine, expanding by 26% and propelling the company to a record Q2 revenue of $163 million. This figure marks a 23% increase compared to the same period last year. This top-line strength flowed through to profitability, with Gross Profit also climbing by 23% to reach $65.2 million.

Institutional Confidence Contrasts with Insider Sales

An examination of the shareholder base reveals a fascinating dynamic. Institutional investors demonstrate overwhelming confidence, holding a commanding 97.31% of all shares. Recent filings show that firms including GAMMA Investing LLC and SG Americas Securities have significantly increased their stakes, a move interpreted as a strong endorsement of the company’s long-term strategy.

This makes a contrasting action by CEO Randolph Altschuler in early July particularly noteworthy. During this period, he sold shares valued at over $302,000. While insider selling can attract scrutiny, the continued and growing dominance of large institutional investors presents a powerful counter-narrative of belief in Xometry’s future.

Ad

Xometry Stock: Buy or Sell?! New Xometry Analysis from August 28 delivers the answer:

The latest Xometry figures speak for themselves: Urgent action needed for Xometry investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 28.

Xometry: Buy or sell? Read more here...

Tags: Xometry
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Micron Stock
Stocks

Micron Capitalizes on AI Demand with Stellar Financial Outlook

August 28, 2025
Cbre Stock
Stocks

CBRE Defies Property Market Headwinds with Stellar Q2 Performance

August 28, 2025
Scotts Miracle-Gro Stock
Stocks

Scotts Miracle-Gro: A Financial Balancing Act of Profit Gains and Dividend Concerns

August 28, 2025
Next Post
Suzano Stock

Suzano's Strategic Shift Yields Impressive Financial Turnaround

Intuitive Surgical Stock

Intuitive Surgical's Workforce Reduction Sparks Investor Concern

Palantir Stock

Palantir's Market Rollercoaster: Valuation Concerns Clash With Record Performance

Recommended

Biotechnology Stock Bull Market

Analyst Maintains Positive Outlook on Endava with Adjusted Price Target

1 year ago

Analyst Ratings and Price Targets for Viridian Therapeutics

1 year ago
Biotechnology Markets and money

Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023

1 year ago
MMM stock news

Piper Sandler Analyst Upgrades Home BancShares Price Target Reflecting Positive Outlook

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB Adobe ADSK AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DELL DIS DWAC Eli Lilly GM IBM INTC Intel LLY META Micron MP Materials MSFT NFLX NIO NVO Opendoor Oracle Palantir PARA PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Institutional Investors Bet on Ceva’s AI and Automotive Revival

Watts Water Stock Surges on Record Quarter and Dividend Payout

Institutional Investors Make Major Moves in Sixth Street Specialty Lending

Institutional Investors Show Diverging Views on Columbus McKinnon

Evolus Shares Continue Downward Trajectory Amid Mixed Signals

SI-Bone’s Strong Growth Meets Insider Selling Activity

Trending

Micron Stock
Stocks

Micron Capitalizes on AI Demand with Stellar Financial Outlook

by Andreas Sommer
August 28, 2025
0

The memory chip sector is experiencing a fundamental shift, and Micron Technology stands at the forefront of...

Cbre Stock

CBRE Defies Property Market Headwinds with Stellar Q2 Performance

August 28, 2025
Scotts Miracle-Gro Stock

Scotts Miracle-Gro: A Financial Balancing Act of Profit Gains and Dividend Concerns

August 28, 2025
Ceva Stock

Institutional Investors Bet on Ceva’s AI and Automotive Revival

August 28, 2025
Watts Water Stock

Watts Water Stock Surges on Record Quarter and Dividend Payout

August 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Micron Capitalizes on AI Demand with Stellar Financial Outlook August 28, 2025
  • CBRE Defies Property Market Headwinds with Stellar Q2 Performance August 28, 2025
  • Scotts Miracle-Gro: A Financial Balancing Act of Profit Gains and Dividend Concerns August 28, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com